Journal
EMBO REPORTS
Volume 19, Issue 12, Pages -Publisher
WILEY
DOI: 10.15252/embr.201845995
Keywords
C/EBP; Foxp3; inflammatory cytokines; iT(reg)
Categories
Funding
- Korean Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C0311]
- National Research Foundation of Korea (NRF) grant - Ministry of Science, ICT and Future Planning (MSIP) [2016R1A2B3013865]
- Korea Mouse Phenotyping Project of the Ministry of Science, ICT and Future Planning through the National Research Foundation [NRF-2014M3A9D5A01073789]
Ask authors/readers for more resources
Proper control of immune responses by Foxp3(+) regulatory T cells at inflamed sites is crucial for the prevention of immunopathology. TGF-beta-induced Foxp3(+) regulatory T (T-reg) cells are generated in inflammatory environments as well as in steady-state conditions. Inflammatory cytokines such as IFN-gamma and IL-4 have an antagonistic effect on T-reg cell conversion. However, it is not known how naive CD4(+) T cells overcome the inhibitory environment in inflamed sites to differentiate into T-reg cells. Here, we show that CCAAT/enhancer-binding protein (C/EBP) functions as a safeguard that enhances T-reg cell generation by dampening the inhibitory effect of IFN-gamma and IL-4 on Foxp3 expression. We find that C/EBP beta is induced by retinoic acid and binds to the methyl-CRE sequence in the Foxp3 TSDR to sustain its expression. C/EBP beta-transduced iT(reg) cells show more potent suppressive activity in mouse disease models. We also reveal that C/EBP beta-transduced human iT(reg) cells exhibit more enhanced suppressor function. These results establish C/EBP as a new molecular target for enhancing the formation and stability of T-reg cells in inflammatory environments.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available